Avelet Remedies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 16 Year, 5 Months
- Last Filing with ROC 31 Mar 2010
- Open Charges ₹ 2.50 M
- Satisfied Charges ₹ 1.80 M
About Avelet Remedies
Avelet Remedies Private Limited (ARPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 August 2008 and has a history of 16 years and five months. Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2010. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.50 M. The company has closed loans amounting to ₹1.80 M, as per Ministry of Corporate Affairs (MCA) records.
Tushar Fadnavis and Padma Fadnavis serve as directors at the Company.
Company Details
-
Location
Nagpur, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239MH2008PTC186273
-
Company No.
186273
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Aug 2008
-
Date of AGM
14 Aug 2010
-
Date of Balance Sheet
31 Mar 2010
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Avelet Remedies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tushar Fadnavis
|
Director | 28-Aug-2008 | Current |
|
Padma Fadnavis
|
Additional Director | 01-Oct-2012 | Current |
Financial Performance of Avelet Remedies.
Enhance accessibility to Avelet Remedies's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Avelet Remedies?
Unlock access to Avelet Remedies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹2.50 M
₹1.80 M
Charges Breakdown by Lending Institutions
- Shikshak Sahakari Bank Limited : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jun 2011 | Shikshak Sahakari Bank Limited | ₹2.50 M | Open |
| 18 Nov 2009 | Bank Of Maharashtra | ₹1.80 M | Satisfied |
How Many Employees Work at Avelet Remedies?
Unlock and access historical data on people associated with Avelet Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Avelet Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avelet Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
